Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73,819,979
-
Total 13F shares
-
19,144,470
-
Share change
-
-6,679,514
-
Total reported value
-
$66,816,077
-
Put/Call ratio
-
25%
-
Price per share
-
$3.49
-
Number of holders
-
106
-
Value change
-
-$456,735,123
-
Number of buys
-
58
-
Number of sells
-
93
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q4 2022
As of 31 Dec 2022 RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,144,470 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, PARSONS CAPITAL MANAGEMENT INC/RI, STATE STREET CORP, and MORGAN STANLEY.
This table shows 106 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.